Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure

Philadelphia‐negative (Ph(−)) myeloproliferative neoplasms (MPN) do rarely transform to acute lymphoblastic leukemia (ALL). While causality is difficult to establish, a few cases of ALL arising after exposure to lenalidomide for registered indications (multiple myeloma, myelodysplastic syndrome with...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhuraiji, Ahmad, Naqvi, Kiran, Huh, Yang O., Ho, Coty, Verstovsek, Srdan, Bose, Prithviraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771935/
https://www.ncbi.nlm.nih.gov/pubmed/29375856
http://dx.doi.org/10.1002/ccr3.1264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771935/
https://www.ncbi.nlm.nih.gov/pubmed/29375856
http://dx.doi.org/10.1002/ccr3.1264

Ejemplares similares